← Leaderboards
Young-In Chi
University Of Kentucky
$1,577,938
Attributed
$1,792,438
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $429K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,792,438 · 5
By mechanism
P20$1,363,438 · 4
R21$429,000 · 1
Top collaborators
- Raul A Urrutia1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Daret K St Clair$20,807,410
- Avindra Nath$17,882,997
- Stephen W Scheff$7,594,722
- Kathryn M Thrailkill$1,641,998
- Mark P Mattson$1,922,482
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsInsulinMolecularTranscription FactorGene TargetingDiabetes MellitusLinkMediatingProtein Protein InteractionStructureGenesMutationDisease-Causing MutationHuman DiseaseFamilyHomeostasisInheritedBinding (Molecular Function)Germ-Line MutationGrantInstitutionGene Expression RegulationAdverse EffectsBase
Grant awards (6)
Insights into EHMT1 Variants in the Neurodevelopmental Disorder Kleefstra Syndrome through Structural Dynamics and Functional Analysis$429,000
R21 · FY2024 · HD
KY COBRE: MECHANISM OF TRANSCRIPTIONAL CONTROL BY TWO DIABETES GENE PRODUCTS$260,773
P20 · FY2008 · RR · contact PI
KY COBRE: MECHANISM OF TRANSCRIPTIONAL CONTROL BY TWO DIABETES GENE PRODUCTS$258,839
P20 · FY2007 · RR · contact PI
KY COBRE: MECHANISM OF TRANSCRIPTIONAL CONTROL BY TWO DIABETES GENE PRODUCTS$259,489
P20 · FY2006 · RR · contact PI
KY COBRE: MECHANISM OF TRANSCRIPTIONAL CONTROL BY TWO DIABETES GENE PRODUCTS$288,690
P20 · FY2005 · RR
TRANSCRIPTIONAL CONTROL BY TWO DIABETES GENE PRODUCTS$295,647
P20 · FY2004 · RR